Brookwood Pharmaceuticals, Scientific Advisory Board Convenes April 2006
April 25, 2006 - Brookwood Pharmaceuticals' Scientific Advisory Board convened for the first time. The Scientific Advisory Board comprises distinguished thought leaders in the fields of biomaterials and drug delivery. The goals for Brookwood's Scientific Advisory Board are to assure we challenge our science with external review and input, keep current with scientific progress, aid in major strategic technical decisions, validate prioritization of technical programs, provide input on new product opportunities, provide input on in-house developed products, and provide clinical and regulatory input.
|
|
Brookwood Pharmaceuticals |
|
James M. Anderson, M.D., Ph.D., Professor of Pathology in Macromolecular Science, and Biomedical Engineering at Case Western Reserve University. Joachim Kohn, Ph.D., Professor of Chemistry in the Department of Chemistry at Rutgers University and Director, New Jersey Center of Biomaterials. Cato T. Laurencin, M.D., Ph.D., Professor, Lillian T. Pratt Distinguished Professor and Chair of the Department of Orthopedic Surgery at University of Virginia. Peter Hoffmann, Ph.D., Vice President, New Technologies, Genzyme Pharmaceuticals. Dennis Fisher, M.D., Principal of the "P <" (P Less Than) Company. |
|
Contact information:
Brookwood Pharmaceuticals
756 Tom Martin Drive
Birmingham, AL 35211
phone 205.917.2200
fax 205.917.2205
Or visit our Contact Page.